MedTrace Logo

Systemic Nalbuphine Versus Intravenous Regional Anesthesia

NCT03150732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2024-02-20

No results posted yet for this study

Summary

Comparison of systemic nalbuphine versus intravenous regional anesthesia in patients undergoing hand surgery.

Conditions

  • Postoperative Pain

Interventions

DRUG

Systemic nalbuphine

Patients will receive systemic nalbuphine 10 mg

DRUG

Local nalbuphine

Patients will receive local nalbuphine 10 mg

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-10
Primary Completion
2024-02-10
Completion
2024-02-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03150732 on ClinicalTrials.gov